Literature DB >> 16236128

Induction of macrophage-derived SLPI by Mycobacterium tuberculosis depends on TLR2 but not MyD88.

Aihao Ding1, Hongwei Yu, Jingxuan Yang, Shuangping Shi, Sabine Ehrt.   

Abstract

Macrophages respond to Mycobacterium tuberculosis by regulating expression of gene products that initiate a host innate response to this micro-organism. In this study, we report that exposure of murine peritoneal macrophages to heat-killed Mycobacterium tuberculosis (HK-Mtb) led to an increase in secretory leucocyte protease inhibitor (SLPI) gene expression and protein secretion in a time- and dose-dependent manner. HK-Mtb-induced SLPI mRNA expression was sensitive neither to a protein synthesis inhibitor, cycloheximide, nor to an actin polymerization blocker, cytochalasin D. Treatment of macrophages with interferon (IFN)-gamma inhibited HK-Mtb-induced SLPI expression. RAW264.7 cells stably expressing SLPI produced a reduced level of tumour necrosis factor (TNF) in response to HK-Mtb as compared with mock transfectants. Aerosol infection of mice with live M. tuberculosis resulted in an induction of SLPI gene expression in infected lungs. Macrophages from Toll-like receptor 4 (TLR4)-/- or MyD88-/- mice responded to M. tuberculosis similarly to wild-type macrophages by exhibiting increased SLPI expression. In contrast, macrophages from TLR2-/- mice were incapable of inducing SLPI in response to M. tuberculosis. This induction signifies the presence of a TLR2-dependent but MyD88-independent M. tuberculosis signalling pathway, suggesting involvement of adaptor protein(s) other than MyD88 in M. tuberculosis-mediated induction of SLPI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236128      PMCID: PMC1802419          DOI: 10.1111/j.1365-2567.2005.02238.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  46 in total

Review 1.  Toll-like receptors: lessons from knockout mice.

Authors:  S Akira
Journal:  Biochem Soc Trans       Date:  2000-10       Impact factor: 5.407

2.  Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia.

Authors:  S R Grobmyer; P S Barie; C F Nathan; M Fuortes; E Lin; S F Lowry; C D Wright; M J Weyant; L Hydo; F Reeves; M U Shiloh; A Ding
Journal:  Crit Care Med       Date:  2000-05       Impact factor: 7.598

3.  Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.

Authors:  E H Noss; R K Pai; T J Sellati; J D Radolf; J Belisle; D T Golenbock; W H Boom; C V Harding
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

4.  Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses.

Authors:  T K Means; B W Jones; A B Schromm; B A Shurtleff; J A Smith; J Keane; D T Golenbock; S N Vogel; M J Fenton
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

5.  TIRAP: an adapter molecule in the Toll signaling pathway.

Authors:  T Horng; G M Barton; R Medzhitov
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

6.  Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.

Authors:  K A Fitzgerald; E M Palsson-McDermott; A G Bowie; C A Jefferies; A S Mansell; G Brady; E Brint; A Dunne; P Gray; M T Harte; D McMurray; D E Smith; J E Sims; T A Bird; L A O'Neill
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

7.  Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response.

Authors:  Chikako Odaka; Toshiaki Mizuochi; Jingxuan Yang; Aihao Ding
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

8.  Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.

Authors:  Aaron A R Tobian; Nicholas S Potter; Lakshmi Ramachandra; Rish K Pai; Marilyn Convery; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

Review 9.  The Toll-IL-1 receptor adaptor family grows to five members.

Authors:  Luke A J O'Neill; Katherine A Fitzgerald; Andrew G Bowie
Journal:  Trends Immunol       Date:  2003-06       Impact factor: 16.687

10.  The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice.

Authors:  T Mogues; M E Goodrich; L Ryan; R LaCourse; R J North
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

View more
  13 in total

1.  Clostridium butyricum activates TLR2-mediated MyD88-independent signaling pathway in HT-29 cells.

Authors:  Quanxin Gao; Lili Qi; Tianxing Wu; Jinbo Wang
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

2.  Divergent Functions of TLR2 on Hematopoietic and Nonhematopoietic Cells during Chronic Mycobacterium tuberculosis Infection.

Authors:  Jill Konowich; Archana Gopalakrishnan; Jillian Dietzold; Sheetal Verma; Kamlesh Bhatt; Wasiulla Rafi; Padmini Salgame
Journal:  J Immunol       Date:  2016-12-05       Impact factor: 5.422

3.  Mycobacterium tuberculosis Hip1 dampens macrophage proinflammatory responses by limiting toll-like receptor 2 activation.

Authors:  Ranjna Madan-Lala; Katia Vitorello Peixoto; Fabio Re; Jyothi Rengarajan
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

Review 4.  C-type lectins with a sweet spot for Mycobacterium tuberculosis.

Authors:  G Lugo-Villarino; D Hudrisier; A Tanne; O Neyrolles
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

5.  The impact of IFN-γ receptor on SLPI expression in active tuberculosis: association with disease severity.

Authors:  Nancy L Tateosian; Virginia Pasquinelli; Rodrigo E Hernández Del Pino; Nella Ambrosi; Diego Guerrieri; Sigifredo Pedraza-Sánchez; Natalia Santucci; Luciano D'Attilio; Joaquín Pellegrini; María A Araujo-Solis; Rosa M Musella; Domingo J Palmero; Rogelio Hernandez-Pando; Verónica E Garcia; H Eduardo Chuluyan
Journal:  Am J Pathol       Date:  2014-03-04       Impact factor: 4.307

6.  TRAM is required for TLR2 endosomal signaling to type I IFN induction.

Authors:  Julianne Stack; Sarah L Doyle; Dympna J Connolly; Line S Reinert; Kate M O'Keeffe; Rachel M McLoughlin; Søren R Paludan; Andrew G Bowie
Journal:  J Immunol       Date:  2014-11-10       Impact factor: 5.422

7.  Role of interferon-γ and inflammatory monocytes in driving colonic inflammation during acute Clostridium difficile infection in mice.

Authors:  Andrew J McDermott; Nicole R Falkowski; Roderick A McDonald; Charles R Frank; Chinmay R Pandit; Vincent B Young; Gary B Huffnagle
Journal:  Immunology       Date:  2017-01-30       Impact factor: 7.397

8.  Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism.

Authors:  Esra Fakioglu; Sarah S Wilson; Pedro M M Mesquita; Ehsan Hazrati; Natalia Cheshenko; John A Blaho; Betsy C Herold
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Campylobacter jejuni drives MyD88-independent interleukin-6 secretion via Toll-like receptor 2.

Authors:  Lorna M Friis; Monika Keelan; Diane E Taylor
Journal:  Infect Immun       Date:  2009-01-12       Impact factor: 3.441

10.  Salmonella Typhimurium Adhesin OmpV Activates Host Immunity To Confer Protection against Systemic and Gastrointestinal Infection in Mice.

Authors:  Deepinder Kaur; Shraddha Gandhi; Arunika Mukhopadhaya
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.